IDXX — IDEXX Laboratories, Inc.
$560.38-1.13%
Last close: · regular session
Last 60 sessions
IDXX closed at $560.38 (-1.13%) on Oct 23, 2026. Float: 78.5M shares. Latest SEC filing: 8-K on May 15, 2026.
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for IDXX in the TickerWise workspace.
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
Company profile
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
- Exchange: NASDAQ
- Employees: 11,000
- Website: https://www.idexx.com
Latest SEC filings for IDXX
Latest IDXX news
- Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth Read article
- Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report? Read article
- Idexx (IDXX) Moves to Buy: Rationale Behind the Upgrade Read article
- IDEXX Laboratories to Release 2026 Third Quarter Financial Results Read article
- Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories Read article
Related companies
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.